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Abstract: The discovery of a bacterium, Helicobacter
pylori, that is resident in the human stomach and causes
chronic disease (peptic ulcer and gastric cancer) was
radical on many levels. Whereas the mouth and the colon
were both known to host a large number of microorgan-
isms, collectively referred to as the microbiome, the
stomach was thought to be a virtual Sahara desert for
microbes because of its high acidity. We now know that H.
pylori is one of many species of bacteria that live in the
stomach, although H. pylori seems to dominate this
community. H. pylori does not behave as a classical
bacterial pathogen: disease is not solely mediated by
production of toxins, although certain H. pylori genes,
including those that encode exotoxins, increase the risk of
disease development. Instead, disease seems to result
from a complex interaction between the bacterium, the
host, and the environment. Furthermore, H. pylori was the
first bacterium observed to behave as a carcinogen. The
innate and adaptive immune defenses of the host,
combined with factors in the environment of the
stomach, apparently drive a continuously high rate of
genomic variation in H. pylori. Studies of this genetic
diversity in strains isolated from various locations across
the globe show that H. pylori has coevolved with humans
throughout our history. This long association has given
rise not only to disease, but also to possible protective
effects, particularly with respect to diseases of the
esophagus. Given this complex relationship with human
health, eradication of H. pylori in nonsymptomatic
individuals may not be the best course of action. The
story of H. pylori teaches us to look more deeply at our
resident microbiome and the complexity of its interac-
tions, both in this complex population and within our
own tissues, to gain a better understanding of health and
disease.
Common wisdom circa 1980 suggested that the stomach, with
its low pH, was a sterile environment. Then, endoscopy of the
stomach became common and, in 1984, pathologist Robin
Warren and gastroenterologist Barry Marshall saw an extracellu-
lar, curved bacillus, often in dense sheets, lining the stomach
epithelium of patients with gastritis (inflammation of the stomach)
and ulcer disease [1]. Soon, the medical community understood
that the gram-negative bacterium Helicobacter pylori, not stress, is
the major cause of stomach inflammation, which, in some infected
individuals, precedes peptic ulcer disease (10%–20%), distal gastric
adenocarcinoma (1%–2%), and gastric mucosal-associated lym-
phoid tissue (MALT) lymphoma (,1%) [2–5]. Thus, H. pylori
gained distinction as the only known bacterial carcinogen [6]. It is
believed that half of the world’s population is infected with H.
pylori; however, the burden of disease falls disproportionately on
less-developed countries. The incidence of infection in developed
countries has fallen dramatically, for unknown reasons, with a
corresponding decrease in gastric cancer [7]. This public health
success is tempered by the recent demonstration of an inverse
relationship between H. pylori infection and esophageal adenocar-
cinoma, Barrett’s esophagus, and reflux esophagitis [8]. H. pylori
has been with humans since our earliest days, thus it is not
surprising that its relationship is that of both a commensal
bacterium and a pathogen, causing some diseases and possibly
protecting against others. In addition, it is genetically diverse,
likely as a result of constant exposure to both environmental and
immunological selection, suggesting that genetic diversification is a
strategy for long-term colonization.
The Role of Infection in Disease Risk
H. pylori infection is generally acquired during childhood and,
without specific antibiotic treatment, can persist for the lifetime of
the host. Disease often does not develop until adulthood, after
decades of infection, and H. pylori induces variable pathologies in
the stomach. Duodenal ulcer disease is characterized by gastritis
that is largely confined to the antrum (the distal compartment of
the stomach), relatively low inflammation of the corpus (the
middle, acid-secreting compartment), and high levels of stomach
acid secretion (Figure 1A). Those with gastric ulcer or stomach
cancer have high levels of inflammation of the corpus, multifocal
gastric atrophy, and low levels of stomach acid secretion, due to
the destruction of stomach acid–secreting parietal cells (Figure 1B)
[9,10]. Some of this inflammatory response is controlled by the
cytokine IL-1b, which is induced by H. pylori infection [11] and
both elicits a proinflammatory response and inhibits secretion of
gastric acid [12]. Polymorphisms in the interleukin gene cluster,
including IL-1b, are risk factors for H. pylori–associated gastric
cancer [13,14], and studies of the transcriptional response of both
human and model hosts to H. pylori confirm induction of
transcriptional regulators of proinflammatory programs. In
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chemokines and cytokines including those produced by nonlym-
phoid cells, and robust induction of innate immune defenses
including iron sequestration proteins and antimicrobial peptides
[15]. These studies suggest it would be wise to explore diverse
functional classes of genes for host genetic variant associations with
H. pylori disease progression. To this end, H. pylori researchers are
eagerly awaiting an unbiased genome-wide association study of
risk factors associated with progression to intestinal-type gastric
cancer or peptic ulcer disease in patients infected with H. pylori.
Such a study has been completed for sporadic diffuse-type gastric
cancer, which can be associated with H. pylori infection, revealing
two candidate loci, one that encodes a likely tumor suppressor
(prostate stem cell antigen [PSCA]) [16]. Genomic studies of this
sort will help elucidate host factors that synergize with H. pylori
infection to cause disease.
The association of H. pylori infection with gastric cancer raises
the interesting question of whether H. pylori encodes one or more
oncogenes. Oncogenic viruses initiate and promote cellular
transformation by integrating virally encoded oncogenes into the
host genome [17,18]. By contrast, H. pylori remains primarily
extracellular and does not integrate its genome into the host DNA.
The bacterium can still affect the function of host cells, however,
by translocating a bacterial protein, CagA, into host cells via a
specialized secretion system called the cag Type IV secretion
system (T4SS) [19,20]. In host cells, CagA interacts with a number
of cellular complexes implicated in oncogenesis [21,22]. Despite
elucidation of potentially transforming activities, transgenic
expression of CagA in the mouse stomach is only weakly
oncogenic [23]. As the cag T4SS also induces proinflammatory
cytokines via the intracellular bacterial peptidoglycan recognition
molecule Nod1, cancer progression may occur through synergy
with the host inflammatory response [24]. While CagA may not
promote cancer itself, exposure to CagA and inflammatory insults
may select for heritable host cell changes (genetic or epigenetic)
that together contribute to cancer progression.
H. pylori expands our view of how microbes survive at high levels
while activating inflammatory responsesand shows us that microbes
may be underappreciated as an important factor in chronic disease
pathogenesis. In the case of pathogens that cause acute infections,
there is a massive inflammatory response, which often supports
bacterial replication and transmission. Alternatively, some patho-
gens, such as Mycobacterium tuberculosis, persist in the host by
manipulating the immune response to create a protected compart-
ment. H. pylori introduces a third strategy; it actively replicates and
maintains a continuous balance with the inflammatory response
over years of infection with little evidence for increased H. pylori–
related disease upon immune suppression [25]. As the role of
chronic inflammation in many diseases including cardiovascular
disease, diabetes mellitus, Alzheimer’s disease, and others is
increasingly recognized, researchers are focusing on infectious
agents as one possible source of this chronic inflammation.
Genomic Insights into the Biology of H. pylori
The study of H. pylori is strongly influenced by the genomic age.
The sequencing of its genome was completed in 1997 [26], just 13
years after Marshall and Warren reported their discovery.
However, almost a quarter (24%) of H. pylori genes have no
sequence similarity with genes available in public databases [27],
suggesting that lessons learned from well-studied bacteria like
Escherichia coli would not necessarily apply to this evolutionarily
distinct Epsilonproteobacteria. By using more advanced bioinfor-
matic approaches, researchers are now identifying some pathways
first thought absent in H. pylori. For example, H. pylori appeared to
lack the E. coli recBCD pathway, which is involved in homologous
recombination and DNA double-strand break repair. More careful
examination of conserved domains and motifs, however, identified
the H. pylori addA and addB genes, which are present in most gram-
positive and many gram-negative bacteria and whose protein
products have enzymatic functions similar to those of the recBCD
pathway [28].
By 1999, H. pylori was the first species to have complete genomes
sequenced from two different strains—an important milestone,
given its genetic diversity. Comparison of the two genomes
revealed that 6%–7% of the genes were present in one strain but
not in the other. There was also a high level of nucleotide diversity
between the two strains, with only eight genes sharing at least 98%
nucleotide identity; however, most nucleotide differences were
synonymous changes [27]. Microarrays designed upon these
sequences were then used for comparative genomic hybridization
of H. pylori strains isolated from different ethnic groups and
geographic areas [29,30]. These studies found that 25% of H. pylori
genes are variably present among strains. Such genome-wide
analyses have played an important role in dividing H. pylori genes
into two classes: variable genes that are absent in some strains and
core genes that are present in all strains analyzed. The variable
genes are likely adaptive for different environmental niches, which
for the human stomach–restricted H. pylori comprise genetically
distinct hosts. The largest annotated class of variable genes encode
proteins expressed on or that modify the bacterial cell surface
(outer membrane proteins and proteins involved in lipopolysac-
charide synthesis) [30], consistent with a function at the interface
of the bacteria and host. The core genes have diverse functions.
Some core genes are required for viability in culture. A genomic
study that utilized microarray-based mapping of a genome-
saturating transposon library (a collection of H. pylori strains that
includes transposon mutants randomly distributed throughout the
genome) revealed that 23% of the genome is required for viability
in culture because these genes could not tolerate transposon
Figure 1. Distinct pathologies of H. pylori–induced disease. (A)
Duodenal ulcer disease correlates with high inflammation in the antrum
(red bursts), lower levels of inflammation in the corpus, and high acid
secretion (+). (B) Gastric ulcer or adenocarcinoma correlates with
increased inflammation in the corpus, low acid secretion, and multifocal
atrophy (wavy lines).
doi:10.1371/journal.ppat.1000544.g001
Learning about Disease from H. pylori
PLoS Pathogens | www.plospathogens.org 2 October 2009 | Volume 5 | Issue 10 | e1000544insertion [31]. Additional core genes are essential only in the
context of host infection and several groups have completed
screens for transposon mutants that fail to colonize animal models
of infection [32,33]. An example of such a colonization core gene
is addA, which is required for recombinational repair of DNA
double-strand breaks, presumably caused by the host inflamma-
tory response [28].
The nucleotide sequence diversity in H. pylori’s core genes can
distinguish between different ethnic and geographic human
populations, demonstrating that passage of H. pylori between
closely related humans has continued uninterrupted over tens of
thousands of years (see Box 1). Different geographic and ethnic
groups that have similar infection rates have quite varied relative
risks of H. pylori–associated diseases such as gastric cancer [34].
Thus, in addition to host genetic and environmental exposures,
differences among strains likely contribute to variation in disease
risk. Consequently, studies of pathogenesis need to be reproduced
in representative strain backgrounds to ensure that discoveries in
one strain apply in strain populations with a diverse evolutionary
history.
H. pylori Diversification during Persistent Infection
Genetic diversification can aid in the persistence of organisms
that continue to replicate during chronic infection, allowing them
to sample adaptive variants. HIV, for example, has a flexible
reverse transcriptase that makes point mutations, insertions,
deletions, transversions, and duplications that produce variants
that may have a selective advantage [35]. Genetic variation in a
microbe indicates constant selection by a dynamic environment,
and H. pylori is a very genetically diverse species of bacteria [36–
38]. Genetic diversification may help H. pylori to adapt to a new
host after transmission, to different micro-niches within a single
host, and to changing conditions in the host over time—for
example, by avoiding clearance by host defenses.
Genetic diversity arises from within-genome diversification as
well as from reassortment by recombination with DNA from other
infecting H. pylori, generating novel clones within the stomach
(Figure 2). Within-genome diversification can include point
mutations, intragenomic recombination, and slipped-strand mis-
pairing during DNA replication within repetitive sequences.
Reassortment can occur by recombination with either DNA from
a superinfecting H. pylori strain or a variant clone of the same
strain. Central to this reassortment is H. pylori’s natural
competence—the ability to take up exogenous DNA and
incorporate it into its genome. Evidence from our lab shows that
natural competence is induced by DNA damage, suggesting that
H. pylori responds to stress by diversifying its genome (MSD and
NRS, unpublished data). However, there are controls on this
rampant genetic exchange: restriction-modification systems, which
include a restriction endonuclease that cleaves a specific DNA
sequence and a DNA methyltransferase that protects the
bacterium’s own DNA from being cleaved by methylating the
target DNA sequence. Genes that encode restriction-modification
systems compose the second largest class of variably present genes
with known function, so the complement of available restriction-
modification systems varies between strains, giving a methylation
code to the DNA from each strain. This mechanism serves to limit
or prevent recombination between H. pylori strains as well as
between H. pylori and other bacteria or eukaryotic cells [39].
The H. pylori genome encodes relatively few proteins that
regulate transcription. Instead, some of the same processes that
govern the generation of genetic diversity (i.e., slipped-strand
mispairing, methyltransferase activity, and recombination) also
play an important role in varying gene expression in response to
environmental cues. There are 46 H. pylori genes that have long
repeats of one or two nucleotides that are prone to slipped-strand
mispairing during replication [26,27,40]. These genes are phase-
variable because changes in the number of repeats can shift the
reading frame of the gene, switching gene expression on or off
(Figure 2). In addition, many H. pylori promoters have mononu-
cleotide repeats that regulate gene expression by changing the
spacing between important regulatory sites in these promoters.
Orphan methyltransferases, which have lost their corresponding
restriction enzyme, may also regulate gene expression by
methylating sequences in the promoter region of genes, and some
of the methyltransferase genes are themselves subject to phase-
variable expression. Recombination regulates gene expression
through deletions and duplications that occur during gene
conversion and locus switching. These mechanisms suggest that
H. pylori survives by constantly generating variants that adapt its
physiology to new environments.
One example of how H. pylori’s genetic variability helps it adapt
to new environments involves its adhesin genes, which encode
proteins that bind to the Lewis human blood group antigens,
which are carbohydrate-based epitopes [41]. The protein encoded
by one of these adhesin genes, BabA, binds the Lewis-b antigen on
the gastric mucosa, helping the bacterium adhere to the mucosa.
The babA gene is silent in some H. pylori strains but can be
Box 1. Tracking Human Genealogy with H.
pylori Genomics
Currently, a number of companies propose to predict your
‘‘genetic genealogy’’ from the DNA in a cheek swab. They
do this by analyzing informatively variable parts of our
genomes (such as the Y chromosome or mitochondrial
DNA) that show characteristic differences between ethnic
and geographic populations; thus, they can tell if you may
be distantly related to Ghengis Khan, for example.
Unfortunately, population bottlenecks [51], small popula-
tion sizes, and long generation times have limited the
amount of genetic diversity in the human population that
can be used for these analyses. It turns out, however, that
genomic sequencing of the H. pylori strain harbored by an
individual does a better job in resolving ancestry than the
usual human genomic markers [52]. This is because of high
genetic diversity among H. pylori strains [53], a restricted
mode of transmission (primarily within families or house-
holds [54]), and the association of H. pylori with humans
throughout our evolution [55]. A major source of H. pylori’s
genetic diversity is recombination between strains [38],
which blurs signatures of descent. Despite this confounding
factor, Achtman and colleagues [53] identified evolutionary
signatures in strain sequences from diverse geographic
sources. These signatures, combined with new statistical
tools that take into account admixture and recombination
[55], have tracked ancient human migrations, such as our
emergence from Africa [55], and more recent events such as
colonization of the Pacific islands [56]. H. pylori gene
sequences can even distinguish between the Buddhist and
Muslim ethnic groups that have coexisted for at least 1,000
years in Ladakh [52]. The fact that H. pylori has maintained
evolutionarily distinct strain signatures during many gener-
ations of contact suggests either thatinterracial interactions
that promote transmission are very limited or that
additional mechanisms prevent strains from one ethnic
population from establishing a foothold in hosts of another
ethnic population.
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by homologous sequences at the 59 and 39 ends of the two genes
[42]. Thus, recombination can help H. pylori alter its adherence
properties to adapt to selective pressures in the host. These
selective pressures may include variation in the host receptors
present or in conditions that favor a shift in the ratio of bacteria
adherent to the gastric cell epithelium over those swimming freely
in the mucus.
Genetic variation may also be important for the ability of H.
pylori to evade the host immune system. H. pylori further exploits
the Lewis antigen system by ‘‘camouflaging’’ its surface lipopoly-
saccharide with its own Lewis-type antigen, which mimics that of
the individual host. The bacterium adapts the spectrum of Lewis
antigens it expresses by phase variation of the genes involved in
their biosynthesis [43]. Furthermore, recombination among the
many members of the large outer membrane protein (omp) gene
family has the potential to create mosaic omp genes, generating
antigenic variation that may keep H. pylori ahead of the ability of
the host’s immune system to recognize these cell surface exposed
epitopes.
H. pylori’s Interaction with the Microbiome
H. pylori share their niche with the stomach microbiome, the
collection of microorganisms living on and in us. Study of
microorganisms was once limited to only those microbes that could
be cultured in the laboratory. Advances in sequencing technology
now allow   us   to study the collection of genes encoded by any
group of organisms—so-called metagenomics—making it possible
to characterize also the microbes that cannot be cultured but
nevertheless affect our health. Given that H. pylori engages in DNA
exchange, the metagenome may serve as a repository for novel
traits. When present, H. pylori dominates the microbiome in the
stomach [44,45], although the effect of this dominance is not
known. Perhaps H. pylori infection changes the composition of the
stomach microbiome, with unknown consequences.
Challenges for the Future
H. pylori is considered pathogenic, even carcinogenic. With this
simple view, eradication seems an obvious choice. In reality,
however, the relationship between H. pylori and disease is more
Figure 2. Mechanisms that create genetic diversity in H. pylori. Colored arrows represent different genes, and the correspondingly colored
triangles, rectangles, and circles represent the proteins encoded by these genes. Diversification mechanisms (right side of figure) include
spontaneous point mutations, slipped-strand mispairing, and intragenomic recombination. Allelic changes involving nonsynonymous point
mutations and mosaic genes resulting from intragenomic recombination can alter the function and/or the antigenic epitopes of the encoded protein.
Gene expression can also be regulated by gene conversion resulting from intragenomic recombination, and phase variation mediated by slipped-
strand mispairing. Reassortment of genes (left side of figure) by natural transformation with exogenous DNA also contributes to genetic diversity.
Natural transformation with DNA from a superinfecting strain, for example, can introduce new genes and new alleles of already present genes
(horizontal gene transfer). Similarly, natural transformation with DNA from a variant clone of the same strain can further propagate an advantageous
allele acquired by within-genome diversification.
doi:10.1371/journal.ppat.1000544.g002
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   nuanced. Like the cancer risk associated with smoking, a recent
trial showed that the cancer risk from H. pylori diminished
measurably only 12 years after eradication of the infection [46].
Some studies suggest that infection may prevent diseases of the
esophagus, and there is a debate in the literature concerning a
relationship between H. pylori and childhood asthma [8,47,48].
There is clear consensus that H. pylori should be eliminated in cases
of peptic ulcer disease, gastric MALT lymphoma, early gastric
cancer, first-degree relatives of gastric cancer patients, and
uninvestigated dyspepsia in high-prevalence populations. Despite
its potential to prevent ulcer and cancer, universal eradication of
H. pylori infection has not gained wide support, because of the
mixture of positive and negative disease associations with infection,
the lack of a definitive bacterial or host molecule accounting for
disease causation, and poor success rates of treating non-ulcer
dyspepsia by clearing H. pylori infection [49,50]. Thus a more
detailed picture of this host–pathogen interaction is needed and
likely will depend upon further advances in both endoscopy and
genomics.
We have a poor understanding of the immune responses to H.
pylori and the reasons that most hosts fail to clear infection. The
host restriction of H. pylori to humans and some nonhuman
primates has hampered development of robust animal models to
study the disease process. Thus progress will require improvements
in animal models and improved access to patient samples.
Endoscopy of the upper gastrointestinal tract is an invasive
procedure, so a major limitation to research is collection of
bacterial and human tissue samples from infected people.
Available samples are biased toward patients with severe
dyspepsia, ulcer symptoms, and gastric cancer, and only a small
fraction of the stomach can be sampled. Advances in less-invasive
methods, such as capsule endoscopy, may allow increased
sampling to monitor bacterial and tissue changes during chronic
colonization, including isolation and phenotypic analysis of
immune effector cells in infected tissue. Less-invasive methods
would also provide an opportunity to study infection in
asymptomatic individuals and transmission of H. pylori infection,
conditions in which the selective pressures that drive the observed
H. pylori genetic diversification likely operate.
A major opportunity to increase our understanding of how H.
pylori causes or prevents disease arises from recent advances in
high-throughput sequencing technologies. Currently, several
platforms allow researchers to accomplish in a single experiment
sequencing or resequencing of tens of H. pylori genomes,
characterization of host immune and epithelial cell types that
change during infection with highly sensitive digital expression tag
analysis, or analysis of the microbiome present in the stomach and
esophagus through metagenomic sequencing or targeted bacterial
or fungal small ribosomal subunit DNA sequencing. The sequence
data generated by such experiments will address several important
mysteries of H. pylori biology, including the timing and extent of H.
pylori genetic diversification. While strains from unrelated
individuals show dramatic variation in gene content and gene
sequence, the extent of sequence variation among clones during
persistent infection of a single host or upon transmission has not
been adequately sampled. Whole-genome sequencing of multiple
isolates of individual patients with dense spatial and temporal
sampling would definitively establish when, where, and by what
mechanisms genetic diversity is generated. This information will
inform efforts to combat resistance to current antibiotics, to
develop vaccines, and to understand H. pylori’s coevolution with
humans. Exploration of the influence of H. pylori on the
microbiome will identify organisms that collaborate with or can
be antagonized by H. pylori. Such organisms may mediate some of
the disease risks that have been associated with H. pylori presence
and absence. Finally, the rapid pace of resequencing of H. pylori’s
human host will provide a deeper understanding of genetic
variation in the human population that may influence risk for H.
pylori–associated pathologies and which, by association, could
provide clues to the cellular pathways disrupted in disease. Thus,
genomic approaches to study host response, the human micro-
biome, bacterial genetic variation, and, perhaps most importantly,
the intersections among these components, will help researchers
determine whether eradication is appropriate for all individuals in
all populations.
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